Cargando…

Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer

The resistance that Triple-Negative Breast Cancer (TNBC), the most aggressive breast cancer subtype, develops against radiotherapy is a complex phenomenon involving several regulators of cell metabolism and gene expression; understanding it is the only way to overcome it. We focused this review on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranza-Martínez, Alberto, Sánchez-Pérez, Julio, Brito-Elias, Luis, López-Camarillo, César, Cantú de León, David, Pérez-Plasencia, Carlos, López-Urrutia, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599982/
https://www.ncbi.nlm.nih.gov/pubmed/34804940
http://dx.doi.org/10.3389/fonc.2021.752270
_version_ 1784601053703962624
author Aranza-Martínez, Alberto
Sánchez-Pérez, Julio
Brito-Elias, Luis
López-Camarillo, César
Cantú de León, David
Pérez-Plasencia, Carlos
López-Urrutia, Eduardo
author_facet Aranza-Martínez, Alberto
Sánchez-Pérez, Julio
Brito-Elias, Luis
López-Camarillo, César
Cantú de León, David
Pérez-Plasencia, Carlos
López-Urrutia, Eduardo
author_sort Aranza-Martínez, Alberto
collection PubMed
description The resistance that Triple-Negative Breast Cancer (TNBC), the most aggressive breast cancer subtype, develops against radiotherapy is a complex phenomenon involving several regulators of cell metabolism and gene expression; understanding it is the only way to overcome it. We focused this review on the contribution of the two leading classes of regulatory non-coding RNAs, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), against ionizing radiation-based therapies. We found that these regulatory RNAs are mainly associated with DNA damage response, cell death, and cell cycle regulation, although they regulate other processes like cell signaling and metabolism. Several regulatory RNAs regulate multiple pathways simultaneously, such as miR-139-5p, the miR-15 family, and the lncRNA HOTAIR. On the other hand, proteins such as CHK1 and WEE1 are targeted by several regulatory RNAs simultaneously. Interestingly, the study of miRNA/lncRNA/mRNA regulation axes increases, opening new avenues for understanding radioresistance. Many of the miRNAs and lncRNAs that we reviewed here can be used as molecular markers or targeted by upcoming therapeutic options, undoubtedly contributing to a better prognosis for TNBC patients.
format Online
Article
Text
id pubmed-8599982
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85999822021-11-19 Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer Aranza-Martínez, Alberto Sánchez-Pérez, Julio Brito-Elias, Luis López-Camarillo, César Cantú de León, David Pérez-Plasencia, Carlos López-Urrutia, Eduardo Front Oncol Oncology The resistance that Triple-Negative Breast Cancer (TNBC), the most aggressive breast cancer subtype, develops against radiotherapy is a complex phenomenon involving several regulators of cell metabolism and gene expression; understanding it is the only way to overcome it. We focused this review on the contribution of the two leading classes of regulatory non-coding RNAs, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), against ionizing radiation-based therapies. We found that these regulatory RNAs are mainly associated with DNA damage response, cell death, and cell cycle regulation, although they regulate other processes like cell signaling and metabolism. Several regulatory RNAs regulate multiple pathways simultaneously, such as miR-139-5p, the miR-15 family, and the lncRNA HOTAIR. On the other hand, proteins such as CHK1 and WEE1 are targeted by several regulatory RNAs simultaneously. Interestingly, the study of miRNA/lncRNA/mRNA regulation axes increases, opening new avenues for understanding radioresistance. Many of the miRNAs and lncRNAs that we reviewed here can be used as molecular markers or targeted by upcoming therapeutic options, undoubtedly contributing to a better prognosis for TNBC patients. Frontiers Media S.A. 2021-11-04 /pmc/articles/PMC8599982/ /pubmed/34804940 http://dx.doi.org/10.3389/fonc.2021.752270 Text en Copyright © 2021 Aranza-Martínez, Sánchez-Pérez, Brito-Elias, López-Camarillo, Cantú de León, Pérez-Plasencia and López-Urrutia https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Aranza-Martínez, Alberto
Sánchez-Pérez, Julio
Brito-Elias, Luis
López-Camarillo, César
Cantú de León, David
Pérez-Plasencia, Carlos
López-Urrutia, Eduardo
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title_full Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title_fullStr Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title_full_unstemmed Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title_short Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
title_sort non-coding rnas associated with radioresistance in triple-negative breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599982/
https://www.ncbi.nlm.nih.gov/pubmed/34804940
http://dx.doi.org/10.3389/fonc.2021.752270
work_keys_str_mv AT aranzamartinezalberto noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT sanchezperezjulio noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT britoeliasluis noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT lopezcamarillocesar noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT cantudeleondavid noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT perezplasenciacarlos noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer
AT lopezurrutiaeduardo noncodingrnasassociatedwithradioresistanceintriplenegativebreastcancer